Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Plaque Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06061471
What this trial is testing

To Evaluate the Efficacy and Safety of AK111 Injection in the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
PsoriasisSkin Diseases
Akeso 454
Very early researchLooking for participantsNCT07337434
What this trial is testing

To Check Comparison of Apremilast and Methotrexate Efficacy in Patients With Moderate to Severe Plaque Psoriasis Presented to Tertiary Care Hospital

Who this might be right for
Chronic Plaque Psoriasis
Syeda Sana Zaman 106
Testing effectiveness (Phase 2)Study completedNCT02576678
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 42
Not applicableStudy completedNCT00769184
What this trial is testing

Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis

Who this might be right for
Psoriasis
NeoStrata Company, Inc. 15
Large-scale testing (Phase 3)UnknownNCT06477237
What this trial is testing

Study of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Huabo Biopharm Co., Ltd. 400
Large-scale testing (Phase 3)Study completedNCT04123795
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate Chronic Plaque PsoriasisSevere Chronic Plaque PsoriasisMixed Guttate/Plaque Psoriasis
UCB Biopharma SRL 49
Large-scale testing (Phase 3)Study completedNCT02698475
What this trial is testing

An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of Age

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 44
Large-scale testing (Phase 3)Study completedNCT04453137
What this trial is testing

Pharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Alvotech Swiss AG 567
Testing effectiveness (Phase 2)Study completedNCT01132612
What this trial is testing

AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis

Who this might be right for
Plaque-type Psoriasis
Novartis Pharmaceuticals 275
Testing effectiveness (Phase 2)Study completedNCT04603027
What this trial is testing

Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis

Who this might be right for
PsoriasisPlaque Psoriasis
Evelo Biosciences, Inc. 249
Large-scale testing (Phase 3)Study completedNCT02714322
What this trial is testing

MYL-1401A Efficacy and Safety Comparability Study to Humira®

Who this might be right for
PsoriasisArthritis, Psoriatic
Mylan Inc. 294
Not applicableStudy completedNCT00799877
What this trial is testing

Chronic Plaque Psoriasis (Ps) Registry

Who this might be right for
Chronic Plaque Psoriasis
AbbVie 6,065
Post-approval studies (Phase 4)Study completedNCT03718299
What this trial is testing

A Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With Psoriasis

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries Limited 55
Testing effectiveness (Phase 2)Study completedNCT04080206
What this trial is testing

A Safety Study of 188-0551 Spray Versus Reference Listed Drug (RLD) in Adult Subjects With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Therapeutics, Inc. 55
Not applicableStudy completedNCT01401452
What this trial is testing

Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 246
Not applicableStudy completedNCT05787236
What this trial is testing

Moderate-to-severe Plaque Psoriasis Patients Response to Secukinumab Treatment in Real-world Setting

Who this might be right for
Moderate-to-severe Plaque Psoriasis
Novartis Pharmaceuticals 79
Large-scale testing (Phase 3)Ended earlyNCT02527421
What this trial is testing

DFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Primus Pharmaceuticals 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT07090330
What this trial is testing

ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Oruka Therapeutics, Inc. 80
Early research (Phase 1)Study completedNCT01582932
What this trial is testing

Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis

Who this might be right for
Psoriasis
Mayne Pharma International Pty Ltd 36
Testing effectiveness (Phase 2)Study completedNCT03384745
What this trial is testing

A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Bond Avillion 2 Development LP 313
Next Page